Both big and small labs have many problems in common but often use different methods to solve them.

The FDA has increased its focus on modernizing the regulation of pharmaceutical manufacturing and drug product quality. As a result, innovative pharmaceutical companies are re-examining whether traditional drug development and commercialization processes are sufficient.

Mutual recognition arrangements (MRAS) are drawing the global accreditation community closer to accepting the outcomes of each other's accreditation.

An unstructured approach to problem solving may not ensure that all voices are heard–that's when the nominal group technique is effective.

A customer relationship management system means a phone call from a client doesn't require them telling a potentially long story, all over again to each person they talk to. It means consistent and updated information as well as satisfied customers.

The most important aspect of a multi-user core facility is that the data generated are accurate and useful for the goals of the researchers.

While the majority of a lab manager's time and effort goes toward managing the performance of human assets, the job also carries a significant responsibility for managing the performance of capital assets.

Hardly a day goes by that someone working in a research laboratory doesn't come up with an idea for a new, improved tool to be used in the discovery process.

Understanding disclosure can prevent the loss of valuable patent rights.

These are not rules to live by; they are rules to enjoy living by.

Presenting an overly commercial presentation at an inappropriate time can hurt your company and your own professional reputation. When is it appropriate and when is it inappropriat to "go commercial?"

A brief look at the value of a formalized communications program.